Could a la carte pricing be a consideration in improving revenue for radiologists in private practice?
|Articles|September 29, 1999
Barco scores Acuson supply deal
Medical imaging and PACS monitor manufacturer Barco Display Systems this month signed a purchase agreement with ultrasound developer Acuson to supply the Mountain View, CA-based company with more than 10,000 custom high-resolution color displays for
Advertisement
Medical imaging and PACS monitor manufacturer Barco Display Systems this month signed a purchase agreement with ultrasound developer Acuson to supply the Mountain View, CA-based company with more than 10,000 custom high-resolution color displays for Acusons Aspen and Sequoia ultrasound platforms. Barcos 14-inch Medical Color Display (MCD 214) will be integrated with the two Acuson systems; MCD 214 features Barcos TrueGrey electronic system, which renders ultrasound images with high image quality and color and gray-scale stability, allowing clinicians to see an exams small details. The Kortrijk, Belgium-based companys 12-inch Medical Color Display (MCD 12) is already being used in Acusons 128XP ultrasound platform.
Advertisement
Related to this article
Catch up on a variety of FDA news in radiology from the past week.
Catch up on the top radiology content of the past week.
Reportedly one of the first FDA-cleared chest X-ray AI software platforms derived from a foundation model, the Chest Xray software facilitates detection and localization of lung nodules, pneumothorax, mediastinal abnormalities and other thoracic abnormalities.
Incorporating structural MRI to improve PET imaging resolution, the MICSI-PET software also offers automated Centiloid quantification from amyloid PET scans.
Emerging research demonstrates the increasing stability of attenuation on clinically relevant VMIs with photon-counting CT and a redefined role of kV that may have implications for longitudinal quantitative CT.
For patients with intermediate-risk prostate cancer, those with lower apparent diffusion coefficient (ADC) values on pre-treatment DWI MRI had a fourfold higher prevalence of distant metastasis in a study with a 10.3-year median follow-up.
In the second of a two-part podcast episode, Lauren Nicola, MD, Christoph Wald, MD, PhD, MBA, and Peter Shen discuss challenges with evaluating value and ROI for AI software, the physician time required to do so, and possible solutions to facilitate improved clarity and consistency with AI reimbursement.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears Software That Combines MRI Enhancement of PET Imaging with Automated Quantification of Amyloid and Tau PET
2
Radiology Roundup of FDA News: September 13 — September 19
3
Is Private Practice Radiology as Important as an Amusement Park?
4
Does kV Still Matter in Photon-Counting CT?
5